{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:21:52Z","timestamp":1789723312983,"version":"4.0.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"name":"The Bloomberg Kimmel Institute for Cancer Immunotherapy"},{"DOI":"10.13039\/100015283","name":"Bloomberg Philanthropies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ustekinumab is a monoclonal antibody therapy targeting interleukin-12 and interleukin-23 for the treatment of inflammatory bowel diseases, including ulcerative colitis (UC). While these pathways remain quite attractive for UC therapy, response to ustekinumab can be variable. There is an urgent need to better understand the underlying mucosal immune alterations associated with treatment to guide therapy decisions. This study aims to examine the mucosal immune signatures in individuals with UC with variable treatment response to ustekinumab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sigmoid colon tissue from individuals treated with ustekinumab were analyzed using a multimodal approach. Single-cell RNA and T cell receptor sequencing was performed on mucosal biopsies. In a subset of these patients, multiparameter flow cytometry and spatial transcriptomics was also completed on matched pre- and post-treatment tissue samples. Key findings were also validated on a larger cohort using immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ustekinumab significantly altered the frequency and phenotype of mucosal regulatory T cells (Tregs). Nonresponders to ustekinumab had a higher frequency of Tregs that expressed OX40 and GITR, which is associated with decreased suppressive abilities. In contrast, responders had Tregs with elevated GPR15 and reduced expression of the kinase PIM2, which can alter Treg stability and function. Additionally, T helper 17 cells in nonresponders demonstrated an enhanced proinflammatory gene expression profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Nonresponse to ustekinumab in UC is linked to a mucosal immune environment enriched with proinflammatory T cell phenotypes and impaired regulatory T cell function. These findings suggest that Tregs are both targets and potential biomarkers of ustekinumab response, with their phenotypic and transcriptional features providing insight into mechanisms of therapeutic resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izag059","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:44:42Z","timestamp":1773924282000},"page":"1138-1152","source":"Crossref","is-referenced-by-count":1,"title":["Ustekinumab resistance in individuals with ulcerative colitis is associated with an alteration of a subset of proinflammatory mucosal regulatory T cells"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-3686","authenticated-orcid":false,"given":"Kristi C","family":"Briggs","sequence":"first","affiliation":[{"name":"Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Tam","sequence":"additional","affiliation":[{"name":"Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Chaaban","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Luo","sequence":"additional","affiliation":[{"name":"Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Kobeissi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lazarev","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Parian","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hackensack University Medical Center , Hackensack, NJ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reezwana","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin M","family":"Selaru","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Department of Biomedical Engineering, Johns Hopkins University , Baltimore, MD,","place":["United States"]},{"name":"Institute for NanoBioTechnology, Johns Hopkins University , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Casella","sequence":"additional","affiliation":[{"name":"Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Shenderov","sequence":"additional","affiliation":[{"name":"Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-1661","authenticated-orcid":false,"given":"Cynthia L","family":"Sears","sequence":"additional","affiliation":[{"name":"Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Housseau","sequence":"additional","affiliation":[{"name":"Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M P","family":"Melia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew M","family":"Pardoll","sequence":"additional","affiliation":[{"name":"Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2026060404341160000_izag059-B1","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as induction and maintenance therapy for ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl J Med"},{"key":"2026060404341160000_izag059-B2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"2026060404341160000_izag059-B3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"2026060404341160000_izag059-B4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.aidm.2015.04.002","article-title":"Interleukin-23p19 expression in patients with ulcerative colitis and its relation to disease severity","volume":"3","author":"El-Bassat","year":"2016","journal-title":"Adv Dig Med"},{"key":"2026060404341160000_izag059-B5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1189\/jlb.0810456","article-title":"The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity","volume":"89","author":"Liu","year":"2011","journal-title":"J Leukoc Biol"},{"key":"2026060404341160000_izag059-B6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/s0016-5085(99)70392-6","article-title":"Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice","volume":"117","author":"Fuss","year":"1999","journal-title":"Gastroenterology"},{"key":"2026060404341160000_izag059-B7","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa033402","article-title":"Anti-interleukin-12 antibody for active Crohn\u2019s disease","volume":"351","author":"Mannon","year":"2004","journal-title":"N Engl J Med"},{"key":"2026060404341160000_izag059-B8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.4049\/jimmunol.1801603","article-title":"The tale of IL-12 and IL-23: a paradigm shift","volume":"202","author":"Khader","year":"2019","journal-title":"J Immunol"},{"key":"2026060404341160000_izag059-B9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/s41467-024-45665-6","article-title":"Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis","volume":"15","author":"Mennillo","year":"2024","journal-title":"Nat Commun"},{"key":"2026060404341160000_izag059-B10","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41590-024-01994-8","article-title":"A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease","volume":"25","author":"Thomas","year":"2024","journal-title":"Nat Immunol"},{"key":"2026060404341160000_izag059-B11","doi-asserted-by":"publisher","first-page":"105760","DOI":"10.1016\/j.isci.2022.105760","article-title":"Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx digital spatial profiling data","volume":"26","author":"van Hijfte","year":"2023","journal-title":"iScience"},{"key":"2026060404341160000_izag059-B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2026060404341160000_izag059-B13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"2026060404341160000_izag059-B14","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"2026060404341160000_izag059-B15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"2026060404341160000_izag059-B16","doi-asserted-by":"publisher","author":"Gennady Korotkevich","DOI":"10.1101\/060012"},{"key":"2026060404341160000_izag059-B17","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"2026060404341160000_izag059-B18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2004.05.004","article-title":"Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease","volume":"113","author":"Wolf","year":"2004","journal-title":"Clin Immunol"},{"key":"2026060404341160000_izag059-B19","doi-asserted-by":"publisher","first-page":"12283","DOI":"10.3748\/wjg.v21.i43.12283","article-title":"Th17 plasticity and its changes associated with inflammatory bowel disease","volume":"21","author":"Ueno","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2026060404341160000_izag059-B20","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1158\/1078-0432.CCR-16-2000","article-title":"A novel murine GITR ligand fusion protein induces antitumor activity as a monotherapy that is further enhanced in combination with an OX40 agonist","volume":"23","author":"Leyland","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2026060404341160000_izag059-B21","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/art.42476","article-title":"Analysis of single-cell transcriptome and surface protein expression in ankylosing spondylitis identifies OX40-positive and glucocorticoid-induced tumor necrosis factor receptor-positive pathogenic Th17 cells","volume":"75","author":"Yi","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2026060404341160000_izag059-B22","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/j.cell.2021.11.018","article-title":"Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity","volume":"184","author":"Schnell","year":"2021","journal-title":"Cell"},{"key":"2026060404341160000_izag059-B23","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1182\/blood-2004-07-2959","article-title":"Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR","volume":"105","author":"Valzasina","year":"2005","journal-title":"Blood"},{"key":"2026060404341160000_izag059-B24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90585","article-title":"Differential expression of GPR15 on T cells during ulcerative colitis","volume":"2","author":"Adamczyk","year":"2017","journal-title":"JCI Insight"},{"key":"2026060404341160000_izag059-B25","doi-asserted-by":"publisher","first-page":"20211","DOI":"10.1074\/jbc.M115.638221","article-title":"Pim-2 kinase influences regulatory T cell function and stability by mediating Foxp3 protein N-terminal phosphorylation","volume":"290","author":"Deng","year":"2015","journal-title":"J Biol Chem"},{"key":"2026060404341160000_izag059-B26","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1038\/s41598-025-90618-8","article-title":"Relating the molecular phenotype of ulcerative colitis to the clinical course","volume":"15","author":"Madill-Thomsen","year":"2025","journal-title":"Sci Rep"},{"key":"2026060404341160000_izag059-B27","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"key":"2026060404341160000_izag059-B28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/ecco-jcc\/jjae012","article-title":"Blocking GPR15 counteracts integrin-dependent T cell gut homing in vivo","volume":"18","author":"Schramm","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026060404341160000_izag059-B29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.immuni.2008.02.019","article-title":"Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis","volume":"28","author":"Izcue","year":"2008","journal-title":"Immunity"},{"key":"2026060404341160000_izag059-B30","doi-asserted-by":"publisher","first-page":"e46241","DOI":"10.1371\/journal.pone.0046241","article-title":"Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-gamma, IL-2 and IL-2R","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"2026060404341160000_izag059-B31","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1038\/s41467-022-33331-8","article-title":"Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy","volume":"13","author":"Pavlidis","year":"2022","journal-title":"Nat Commun"},{"key":"2026060404341160000_izag059-B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmgh.2020.07.005","article-title":"Ustekinumab inhibits T follicular helper cell differentiation in patients with Crohn\u2019s disease","volume":"11","author":"Globig","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026060404341160000_izag059-B33","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2019.09.002","article-title":"Suppressive and gut-reparative functions of human type 1 T regulatory cells","volume":"157","author":"Cook","year":"2019","journal-title":"Gastroenterology"},{"key":"2026060404341160000_izag059-B34","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/gutjnl-2015-310022","article-title":"Differential effects of alpha4beta7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo","volume":"65","author":"Fischer","year":"2016","journal-title":"Gut"},{"key":"2026060404341160000_izag059-B35","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41385-021-00390-x","article-title":"The aryl hydrocarbon receptor regulates expression of mucosal trafficking receptor GPR15","volume":"14","author":"Swaminathan","year":"2021","journal-title":"Mucosal Immunol"},{"key":"2026060404341160000_izag059-B36","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1038\/s41467-023-43211-4","article-title":"Dietary L-Tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15","volume":"14","author":"Van","year":"2023","journal-title":"Nat Commun"},{"key":"2026060404341160000_izag059-B37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ni.3079","article-title":"Role and species-specific expression of colon T cell homing receptor GPR15 in colitis","volume":"16","author":"Nguyen","year":"2015","journal-title":"Nat Immunol"},{"key":"2026060404341160000_izag059-B38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2024.10.003","article-title":"Engineering therapeutic regulatory T cells to overexpress g protein-coupled receptor 15 improves functional fitness for in vivo gut homing","volume":"168","author":"Muller","year":"2025","journal-title":"Gastroenterology"},{"key":"2026060404341160000_izag059-B39","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/ibd\/izae024","article-title":"Two-year efficacy and safety of mirikizumab following 104 weeks of continuous treatment for ulcerative colitis: results from the LUCENT-3 open-label extension study","volume":"30","author":"Sands","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026060404341160000_izag059-B40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa2314585","article-title":"Risankizumab versus ustekinumab for moderate-to-severe Crohn\u2019s disease","volume":"391","author":"Peyrin-Biroulet","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/6\/1138\/68087180\/izag059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/6\/1138\/68087180\/izag059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:34:22Z","timestamp":1780562062000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/6\/1138\/8654466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,4,15]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag059","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,15]]}}}